(Q42466825)

English

Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Rohit Bhargava

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sushil Beriwal

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

David J Dabbs

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Umut Ozbek

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Atilla Soran

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Ronald R Johnson

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Adam M Brufsky

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Barry C Lembersky

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Gretchen M Ahrendt

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1431-1439

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Preoperative (neoadjuvant) systemic treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of resistance to systemic therapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathologic variables predict Oncotype DX recurrence score

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Supervised risk predictor of breast cancer based on intrinsic subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Luminal B breast tumors are not HER2 positive

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24876

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24876

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42466825&oldid=1958535574"